129 related articles for article (PubMed ID: 30383728)
1. Hydrogen peroxide 40% (Eskata) for seborrheic keratoses.
Med Lett Drugs Ther; 2018 Sep; 60(1556):157-158. PubMed ID: 30383728
[No Abstract] [Full Text] [Related]
2. Hydrogen Peroxide 40% (Eskata) for Seborrheic Keratosis.
Robertson S; Franko J
Am Fam Physician; 2019 Nov; 100(10):643-644. PubMed ID: 31730314
[No Abstract] [Full Text] [Related]
3. The efficacy and morphological effects of hydrogen peroxide 40% topical solution for the treatment of seborrheic keratoses, evaluated by dynamic optical coherence tomography.
Forouzandeh M; Rajabi-Estarabadi A; Williams NM; Avanaki MRN; Nouri K
Skin Res Technol; 2020 Jan; 26(1):142-145. PubMed ID: 31338893
[No Abstract] [Full Text] [Related]
4. Eskata® (Hydrogen Peroxide 40%)-A Treatment for Seborrheic Keratosis.
Gupta AK; Versteeg SG; Abramovits W; Patel S; Vincent KD
Skinmed; 2019; 17(4):268-270. PubMed ID: 31627790
[No Abstract] [Full Text] [Related]
5. Hydrogen Peroxide Topical Solution, 40% (w/w) for the Treatment of Seborrheic Keratoses: A Review.
Murphy EC; Friedman AJ
Skin Therapy Lett; 2020 Jan; 25(1):1-4. PubMed ID: 32023021
[TBL] [Abstract][Full Text] [Related]
6. Eskata (40% Hydrogen Peroxide Solution) for the Treatment of Seborrheic Keratoses.
Keaney T
J Drugs Dermatol; 2019 Jul; 18(7):s172. PubMed ID: 31336412
[TBL] [Abstract][Full Text] [Related]
7. Hydrogen Peroxide 40% for the Treatment of Seborrheic Keratoses.
Funkhouser CH; Coerdt KM; Haidari W; Cardis MA
Ann Pharmacother; 2021 Feb; 55(2):216-221. PubMed ID: 32646224
[TBL] [Abstract][Full Text] [Related]
8. Comparison of efficacy and safety of 30% hydrogen peroxide with 50% trichloroacetic acid in seborrheic keratosis: a randomized controlled study.
Agrawal D; Adil M; Amin SS; Mohtashim M; Bansal R; Tabassum H
Ital J Dermatol Venerol; 2021 Aug; 156(4):489-495. PubMed ID: 32348081
[TBL] [Abstract][Full Text] [Related]
9. Clinical Experience With 40% Hydrogen Peroxide Topical Solution for the Treatment of Seborrheic Keratosis.
Peredo M; Murphy E; Karibayeva D
J Drugs Dermatol; 2019 Jul; 18(7):s173-177. PubMed ID: 31336413
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of topical treatments for seborrheic keratoses: a systematic review.
Natarelli N; Krenitsky A; Hennessy K; Moore S; Grichnik J
J Dermatolog Treat; 2023 Dec; 34(1):2133532. PubMed ID: 36215682
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of hydrogen peroxide topical solution, 40% (w/w), in patients with seborrheic keratoses: Results from 2 identical, randomized, double-blind, placebo-controlled, phase 3 studies (A-101-SEBK-301/302).
Baumann LS; Blauvelt A; Draelos ZD; Kempers SE; Lupo MP; Schlessinger J; Smith SR; Wilson DC; Bradshaw M; Estes E; Shanler SD
J Am Acad Dermatol; 2018 Nov; 79(5):869-877. PubMed ID: 29864467
[TBL] [Abstract][Full Text] [Related]
12. Hydrogen peroxide and povidone-lodine solution--a dangerous combination.
Health Devices; 2011 Feb; 40(2):75. PubMed ID: 23444560
[TBL] [Abstract][Full Text] [Related]
13. Anatomic Site-Specific Treatment Response With 40% Hydrogen Peroxide (w/w) Topical Formulation for Raised Seborrheic Keratoses: Pooled Analysis of Data from Two Phase 3 Studies.
Smith SR; Xu S; Estes E; Shanler SD
J Drugs Dermatol; 2018 Oct; 17(10):1092-1098. PubMed ID: 30365590
[TBL] [Abstract][Full Text] [Related]
14. Utility of 30% hydrogen peroxide in the treatment of seborrheic keratosis.
Suvarna P; Kayarkatte MN
Int J Dermatol; 2022 Sep; 61(9):1113-1116. PubMed ID: 35094378
[TBL] [Abstract][Full Text] [Related]
15. A-101, a Proprietary Topical Formulation of High-Concentration Hydrogen Peroxide Solution: A Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study of the Dose-Response Profile in Subjects With Seborrheic Keratosis of the Face.
DuBois JC; Jarratt M; Beger BB; Bradshaw M; Powala CV; Shanler SD
Dermatol Surg; 2018 Mar; 44(3):330-340. PubMed ID: 28902028
[TBL] [Abstract][Full Text] [Related]
16. Assessing Patients' Satisfaction With Hydrogen Peroxide Topical Solution, 40% for Treatment of Raised Seborrheic Keratoses.
DuBois J; Grande K; Rhodes T; Schnyder J; Shanler SD
J Drugs Dermatol; 2020 Dec; 19(12):1184-1191. PubMed ID: 33346520
[TBL] [Abstract][Full Text] [Related]
17. The search for topical treatments for seborrheic keratoses continues.
Burkhart CG
Int J Dermatol; 2006 Sep; 45(9):1110. PubMed ID: 16961526
[No Abstract] [Full Text] [Related]
18. Ex vivo evaluation of cytotoxicity and melanocyte viability after A-101 hydrogen peroxide topical solution 40% or cryosurgery treatment in seborrheic keratosis lesions.
Kao S; Kiss A; Efimova T; Friedman A
J Am Acad Dermatol; 2018 Oct; 79(4):767-768. PubMed ID: 29601933
[No Abstract] [Full Text] [Related]
19. The expression of p63 in actinic keratoses, seborrheic keratosis, and cutaneous squamous cell carcinomas.
Wrone DA; Yoo S; Chipps LK; Moy RL
Dermatol Surg; 2004 Oct; 30(10):1299-302. PubMed ID: 15458526
[TBL] [Abstract][Full Text] [Related]
20. Enhancing Outcomes in Seborrheic Keratosis: Using a Novel Treatment Solution.
Schlesinger TE; Favre C
J Drugs Dermatol; 2019 Jul; 18(7):s178-182. PubMed ID: 31336414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
